Investing in Health Equity | Why Massachusetts Should Ensure Access to FDA-Approved Anti-Obesity Medications
October 2026
Massachusetts’ Medicaid program, MassHealth, decided to end coverage for GLP-1s, one of the most effective treatments for obesity. While this decision may…
PDF



